These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30172736)

  • 1. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
    Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
    Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
    Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
    J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM
    Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Alzahrani MZ; Bakheet SA; Attia SM
    Neuromolecular Med; 2018 Mar; 20(1):133-146. PubMed ID: 29468499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM
    Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
    Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM
    Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
    Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
    Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
    Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Mazroua HA; Khan MR; Alasmari AF; Alanazi WA; As Sobeai HM; Attia SM
    Mol Immunol; 2019 Oct; 114():561-570. PubMed ID: 31522074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism.
    Bakheet SA; Alzahrani MZ; Ansari MA; Nadeem A; Zoheir KMA; Attia SM; Al-Ayadhi LY; Ahmad SF
    Mol Neurobiol; 2017 Sep; 54(7):5201-5212. PubMed ID: 27578011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T
    Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Albekairi TH; Bakheet SA; Alobaidi AF; Alhosaini K; Alqarni SA; Ibrahim KE; Alsaad AMS; Ahmad SF
    Immunol Lett; 2022 Apr; 244():19-27. PubMed ID: 35259423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alshammari MA; Attia SM
    Neurochem Int; 2018 Nov; 120():251-261. PubMed ID: 30227151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T
    Ansari MA; Attia SM; Nadeem A; Bakheet SA; Raish M; Khan TH; Al-Shabanah OA; Ahmad SF
    Mol Cell Neurosci; 2017 Jul; 82():76-87. PubMed ID: 28465254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alzahrani MZ; Alshammari MA; Alanazi WA; Alasmari AF; Attia SM
    Eur J Pharmacol; 2018 Jun; 829():70-78. PubMed ID: 29654783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T
    Albekairi NA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Alanazi MM; Alhamed AS; Albekairi TH; Al-Mazroua HA; Ibrahim KE; Ahmad SF
    Pharmacol Biochem Behav; 2022 Jun; 217():173408. PubMed ID: 35644272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M
    Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
    Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF
    J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.